NEWS
View news from our Featured Companies.
Greenfire Resources Announces Q1 2024 Results and Reiterates 2024 Outlook
Calgary, Alberta--(May 15, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the sustainable production and development of thermal energy resources from the Athabasca region of Alberta,...
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024
CARMEL, Ind., May 15, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized...
Precision Optics Reports Third Quarter Fiscal Year 2024 Financial Results
Conference Call Scheduled for today, May 15, 2024, at 5:00pm ETGARDNER, Mass., May 15, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced...
INVO Reports Record First Quarter 2024 Financial Results
353% Revenue Growth with improvement in Adjusted EBITDASARASOTA, Fla., May 15, 2024 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the...
Mogo Launches “Buffett Mode” Self-Directed Investing App – the Perfect Antidote to Combat Meme Stock Gambling
Warren Buffett has criticized trading platforms for gamifying investing and resembling gambling parlours1 Buffett Mode is designed to gamify thoughtful long-term investing by giving investors the behavioral edge they need to minimize gambling and speculating, and...
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
- 358 enrolled and 223 patients currently on treatment across sites in the USA, Europe and Asia - - Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia - - Topline data from 1-year open-label extension (OLE) trial expected...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
PORTLAND, Maine, May 14, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Gained alignment with U.S. Food and Drug Administration (FDA) on brilaroxazine clinical trials for New Drug Application (NDA) submission in schizophrenia - - Registrational RECOVER-2 trial expected to initiate Q2 2024; topline data expected Q3 2025 - - Topline data...
LiqTech International Announces First Quarter 2024 Financial Results
BALLERUP, Denmark, May 14, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the first quarter of 2024. Q1 2024...
S&W Announces Third Quarter Fiscal 2024 Financial Results
LONGMONT, Colo., May 14, 2024 -- S&W Seed Company (Nasdaq: SANW) today announced financial results for the three months ended March 31, 2024. Financial Highlights Revenue for the third quarter of fiscal 2024 was $18.3 million, a 3.7% increase compared to the third...
LiqTech and Franman Enter Agreement for Marine Scrubber Water Treatment Solutions for the Greek Market
BALLERUP, Denmark and HOUSTON and ATHENS, Greece , May 14, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems for marine, and Franman, a well-established...
Greenfire Resources Announces Release Timing for Q1 2024 Results and Conference Call
Calgary, Alberta--(May 13, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the sustainable production and development of thermal energy resources from the Athabasca region of Alberta,...
Mogo to Participate in EF Hutton Annual Global Conference
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a digital wealth and payments business, today announced that it will be participating in the EF Hutton Annual Global Conference, which is being held on May 15th at The Plaza...
Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference
CUPERTINO, Calif., May 13, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Scientific Industries to Host First Quarter 2024 Financial Results Investor Call on May 16, 2024
Investor Call to be held at 11:00 AM Eastern Time BOHEMIA, NY / May 10, 2024 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today it plans file the Form 10Q on May...
S&W Seed Company Announces Commercial Launch of Double Team Forage Sorghum
LONGMONT, Colo., May 10, 2024 -- S&W Seed Company (Nasdaq: SANW), a global agricultural technology company, today announced the expansion of its novel and proprietary sorghum trait technology portfolio with the commercial launch of Double Team Forage Sorghum....
Mogo Extends Maturity of $60 Million Credit Facility to 2026
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a digital wealth and payments business, today announced an amendment to its existing senior credit facility ("Credit Facility") with funds managed by affiliates of Fortress...
Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease
Phase 2 trial for KIO-301 for the treatment of retinitis pigmentosa, in partnership with Théa Open Innovation, expected to be initiated in Q4 2024Phase 2 clinical trial for KIO-104 for retinal inflammation expected to begin in 2025 Ended Q1 2024 with $31.3...
SenesTech Announces First Quarter 2024 Financial Results
PHOENIX, May 9, 2024 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced...
Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update
PONTE VEDRA, Fla., May 9, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths due to blood...
Precision Optics Announces Record $9 Million Production Order for High Volume Single-Use Cystoscopy Surgery Program
GARDNER, Mass., May 09, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced a $9 million production order from a leading surgical company...
Mogo Reports Results for Q1 2024
Record quarterly revenue of $17.9 million, up 13% year-over-year, accelerating for second consecutive quarter Total AUM increased 22% year-over-year to over $400 million (MogoTrade Assets up 150% year-over-year) Quarterly payments volume increased 18% year-over-year...
Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting
CUPERTINO, Calif., May 09, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
InfuSystem Reports First Quarter 2024 Financial Results
Record Net Revenues of $32.0 million Representing 5% Growth from the Prior Year Gross Profit increased 10% - Gross Margin of 51.5%, an increase of 2.3% ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading...
Precision Optics Corporation Schedules Third Quarter of Fiscal Year 2024 Conference Call for Wednesday, May 15, 2024
GARDNER, Mass., May 08, 2024 -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call to...